
Sanjay Shankar Deshpande
About Sanjay Shankar Deshpande
Data last updated:
Sanjay Shankar Deshpande has 22 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Fortytwo42 Labs Llp and Fortytwo42 Labs Private Limited. Formerly with 2 companies. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Fortytwo42 Labs Private Limited U62099PN2026PTC253991 | Director | 31 Mar 2026 | 2026 | Active |
Blueroad Technologies Private Limited U72200PN2003PTC018692 | Director | 26 Dec 2003 | 2003 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Fortytwo42 Labs Llp AAH-7902 | Designated Partner | 10 Nov 2016 | 2016 | Converted And Dissolved |
Uniken Technology Innovations Private Limited U72300PN2004PTC019342 | Director | 07 Apr 2008 | 2004 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Shankar Deshpande
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Shankar Deshpande
Sanjay Shankar Deshpande has 22 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Fortytwo42 Labs Llp and Fortytwo42 Labs Private Limited. Formerly with 2 companies. Engaged in General Business, Technology. Contributes to corporate operations.
Sanjay Shankar Deshpande is associated with 2 companies as Designated Partner and Director.
Sanjay Shankar Deshpande has expertise in General Business, Technology.
Sanjay Shankar Deshpande has 22 years in corporate governance.